Literature DB >> 27324473

Plasma miR-187* is a potential biomarker for oral carcinoma.

Chung-Ji Liu1,2,3,4, Jiun-Sheng Lin1, Hui-Wen Cheng3, Ya-Hui Hsu4, Chieh-Yuan Cheng1, Shu-Chun Lin5,6.   

Abstract

OBJECTIVES: Oral squamous cell carcinoma (OSCC) is prevalent worldwide, and survival in OSCC has not improved significantly in the past decades. MicroRNAs (miRNAs) have an important regulatory role in oral carcinogenesis. This study investigated the functional and clinical implications of miR-187* in OSCC pathogenesis.
MATERIALS AND METHODS: Expression of miR-187* in OSCC tissues and patient plasma was assayed using quantitative RT-PCR. The diagnostic power was specified using receiver operator curve analysis. The phenotypic influence of miR-187* in OSCC cells was delineated using exogenous expression.
RESULTS: miR-187* was upregulated in OSCC tissue relative to control mucosa. Overexpression of miR-187* enhanced the oncogenic phenotype of OSCC cells, including cell migration and anchorage-independent colony formation. Plasma miR-187* levels could be used to distinguish patients from controls with a separating power of 0.73. Patients showing a reduction in plasma miR-187* after tumor resection had a better prognosis.
CONCLUSION: miR-187* plays oncogenic roles in oral carcinogenesis. Plasma miR-187* could be validated as a marker of OSCC for diagnostic uses. CLINICAL RELEVANCE: This research implied that plasma miR-187* was a diagnostic marker for patients with OSCC, and plasma miR-187* level could be a prognostic factor for OSCC patients who received ablation surgery.

Entities:  

Keywords:  Carcinoma; MicroRNA; Mouth; Plasma; miR-187*

Mesh:

Substances:

Year:  2016        PMID: 27324473     DOI: 10.1007/s00784-016-1887-z

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  40 in total

1.  miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma.

Authors:  Chung-Ji Liu; Meng-Miao Tsai; Pei-Shih Hung; Shou-Yen Kao; Tsung-Yun Liu; Kou-Juey Wu; Shih-Hwa Chiou; Shu-Chun Lin; Kuo-Wei Chang
Journal:  Cancer Res       Date:  2010-02-09       Impact factor: 12.701

2.  Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.

Authors:  A Chao; C-Y Lin; Y-S Lee; C-L Tsai; P-C Wei; S Hsueh; T-I Wu; C-N Tsai; C-J Wang; A-S Chao; T-H Wang; C-H Lai
Journal:  Oncogene       Date:  2011-07-04       Impact factor: 9.867

3.  Analysis of microRNA expression profiling identifies miR-155 and miR-155* as potential diagnostic markers for active tuberculosis: a preliminary study.

Authors:  Jing Wu; Chanyi Lu; Ni Diao; Shu Zhang; Sen Wang; Feifei Wang; Yan Gao; Jiazhen Chen; Lingyun Shao; Jingning Lu; Xuelian Zhang; Xinhua Weng; Honghai Wang; Wenhong Zhang; Yuxian Huang
Journal:  Hum Immunol       Date:  2011-10-14       Impact factor: 2.850

4.  Association between the rs2910164 polymorphism in pre-mir-146a and oral carcinoma progression.

Authors:  Pei-Shi Hung; Kuo-Wei Chang; Shou-Yen Kao; Ting-Hui Chu; Chung-Ji Liu; Shu-Chun Lin
Journal:  Oral Oncol       Date:  2011-12-17       Impact factor: 5.337

5.  miR-155 and its star-form partner miR-155* cooperatively regulate type I interferon production by human plasmacytoid dendritic cells.

Authors:  Haibo Zhou; Xinfang Huang; Huijuan Cui; Xiaobing Luo; Yuanjia Tang; Shunle Chen; Li Wu; Nan Shen
Journal:  Blood       Date:  2010-09-17       Impact factor: 22.113

6.  MicroRNA profiling of Barrett's oesophagus and oesophageal adenocarcinoma.

Authors:  B P L Wijnhoven; D J Hussey; D I Watson; A Tsykin; C M Smith; M Z Michael
Journal:  Br J Surg       Date:  2010-06       Impact factor: 6.939

7.  Target-mediated protection of endogenous microRNAs in C. elegans.

Authors:  Saibal Chatterjee; Monika Fasler; Ingo Büssing; Helge Grosshans
Journal:  Dev Cell       Date:  2011-03-15       Impact factor: 12.270

8.  MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis.

Authors:  Mark Bloomston; Wendy L Frankel; Fabio Petrocca; Stefano Volinia; Hansjuerg Alder; John P Hagan; Chang-Gong Liu; Darshna Bhatt; Cristian Taccioli; Carlo M Croce
Journal:  JAMA       Date:  2007-05-02       Impact factor: 56.272

9.  Upregulation of miR-372 and -373 associates with lymph node metastasis and poor prognosis of oral carcinomas.

Authors:  Hsi-Feng Tu; Kuo-Wei Chang; Hui-Wen Cheng; Chung-Ji Liu
Journal:  Laryngoscope       Date:  2015-07-07       Impact factor: 3.325

10.  MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor.

Authors:  Jinsong Li; Hongzhang Huang; Lijuan Sun; Mei Yang; Chaobin Pan; Weiliang Chen; Donghui Wu; Zhaoyu Lin; Chunxian Zeng; Yandan Yao; Peter Zhang; Erwei Song
Journal:  Clin Cancer Res       Date:  2009-06-09       Impact factor: 12.531

View more
  8 in total

Review 1.  Prospective applications of microRNAs in oral cancer.

Authors:  Chuan Fang; Yadong Li
Journal:  Oncol Lett       Date:  2019-08-16       Impact factor: 2.967

2.  LncRNA LINC01303 Promotes the Progression of Oral Squamous Cell Carcinomas via the miR-429/ZEB1/EMT Axis.

Authors:  Bo Sun; Xianyu Zheng; Weilong Ye; Pengcheng Zhao; Guowu Ma
Journal:  J Oncol       Date:  2021-12-06       Impact factor: 4.375

Review 3.  Promising Biomarkers in Head and Neck Cancer: The Most Clinically Important miRNAs.

Authors:  Arsinoe C Thomaidou; Panagiota Batsaki; Maria Adamaki; Maria Goulielmaki; Constantin N Baxevanis; Vassilis Zoumpourlis; Sotirios P Fortis
Journal:  Int J Mol Sci       Date:  2022-07-26       Impact factor: 6.208

4.  Blood-based circulating microRNAs as potential biomarkers for predicting the prognosis of head and neck cancer-a systematic review.

Authors:  Shankargouda Patil; Saman Warnakulasuriya
Journal:  Clin Oral Investig       Date:  2020-10-03       Impact factor: 3.573

Review 5.  Functional Landscape of Dysregulated MicroRNAs in Oral Squamous Cell Carcinoma: Clinical Implications.

Authors:  Ruma Dey Ghosh; Arun Pattatheyil; Susanta Roychoudhury
Journal:  Front Oncol       Date:  2020-05-12       Impact factor: 6.244

6.  Circulating MicroRNAs as Prognostic Molecular Biomarkers in Human Head and Neck Cancer: A Systematic Review and Meta-Analysis.

Authors:  Shree Ram Lamichhane; Thanuja Thachil; Harriet Gee; Natalie Milic
Journal:  Dis Markers       Date:  2019-11-18       Impact factor: 3.434

Review 7.  Cell-Free microRNAs as Potential Oral Cancer Biomarkers: From Diagnosis to Therapy.

Authors:  Óscar Rapado-González; Rafael López-López; José Luis López-Cedrún; Gabriel Triana-Martínez; Laura Muinelo-Romay; María Mercedes Suárez-Cunqueiro
Journal:  Cells       Date:  2019-12-17       Impact factor: 6.600

Review 8.  MicroRNAs as Modulators of Oral Tumorigenesis-A Focused Review.

Authors:  Kumar Rishabh; Soham Khadilkar; Aviral Kumar; Ishu Kalra; Alan Prem Kumar; Ajaikumar B Kunnumakkara
Journal:  Int J Mol Sci       Date:  2021-03-04       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.